Using the therapy and enhancement distinction in law and policy
In a first major study, the UK’s Royal Society found that 76% of people in the UK are in favour of therapeutic germline genomic editing to correct genetic diseases in human embryos, but found there was little appetite for germline genomic editing for non-therapeutic purposes. Assuming the UK and oth...
| Main Author: | |
|---|---|
| Format: | Electronic Article |
| Language: | English |
| Check availability: | HBZ Gateway |
| Journals Online & Print: | Drawer...
|
| Fernleihe: | Fernleihe für die Fachinformationsdienste |
| Published: |
Wiley-Blackwell
[2020]
|
| In: |
Bioethics
Year: 2020, Volume: 34, Issue: 1, Pages: 70-80 |
| IxTheo Classification: | NCH Medical ethics XA Law ZC Politics in general |
| Further subjects: | B
Policy
B Therapy B Law B Allen Buchanan B John Harris B Regulation B germline genome editing B Enhancement |
| Online Access: |
Volltext (Verlag) Volltext (doi) |
MARC
| LEADER | 00000caa a22000002 4500 | ||
|---|---|---|---|
| 001 | 1727468880 | ||
| 003 | DE-627 | ||
| 005 | 20230426130545.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200819s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/bioe.12662 |2 doi | |
| 035 | |a (DE-627)1727468880 | ||
| 035 | |a (DE-599)KXP1727468880 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 1 |2 ssgn | ||
| 100 | 1 | |e VerfasserIn |0 (DE-588)128779500 |0 (DE-627)379680769 |0 (DE-576)297328883 |4 aut |a McGee, Andrew |d 1958- | |
| 109 | |a McGee, Andrew 1958- |a MacGee, Andrew 1958- |a Mc Gee, Andrew 1958- | ||
| 245 | 1 | 0 | |a Using the therapy and enhancement distinction in law and policy |
| 264 | 1 | |c [2020] | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a In a first major study, the UK’s Royal Society found that 76% of people in the UK are in favour of therapeutic germline genomic editing to correct genetic diseases in human embryos, but found there was little appetite for germline genomic editing for non-therapeutic purposes. Assuming the UK and other governments acted on these findings, can lawmakers and policymakers coherently regulate the use of biomedical innovations by permitting their use for therapeutic purposes but prohibiting their use for enhancement purposes? This paper examines the very common claim in the enhancement literature that the therapy v enhancement distinction does little meaningful work in helping us think through the ethical issues, a claim that has significant implications for these lawmakers and policymakers who may wish to regulate genomic editing techniques to reflect the findings of this important study. The focus of this paper is on germline genomic editing as one of the main themes in this special issue. | ||
| 601 | |a Therapie | ||
| 650 | 4 | |a Allen Buchanan | |
| 650 | 4 | |a John Harris | |
| 650 | 4 | |a Enhancement | |
| 650 | 4 | |a germline genome editing | |
| 650 | 4 | |a Law | |
| 650 | 4 | |a Policy | |
| 650 | 4 | |a Regulation | |
| 650 | 4 | |a Therapy | |
| 652 | |a NCH:XA:ZC | ||
| 773 | 0 | 8 | |i Enthalten in |t Bioethics |d Oxford [u.a.] : Wiley-Blackwell, 1987 |g 34(2020), 1, Seite 70-80 |h Online-Ressource |w (DE-627)271596708 |w (DE-600)1480658-7 |w (DE-576)078707986 |x 1467-8519 |7 nnns |
| 773 | 1 | 8 | |g volume:34 |g year:2020 |g number:1 |g pages:70-80 |
| 856 | 4 | 0 | |u https://onlinelibrary.wiley.com/doi/abs/10.1111/bioe.12662 |x Verlag |
| 856 | |u https://doi.org/10.1111/bioe.12662 |x doi |3 Volltext | ||
| 936 | u | w | |d 34 |j 2020 |e 1 |h 70-80 |
| 951 | |a AR | ||
| ELC | |a 1 | ||
| ITA | |a 1 |t 1 | ||
| LOK | |0 000 xxxxxcx a22 zn 4500 | ||
| LOK | |0 001 3741222720 | ||
| LOK | |0 003 DE-627 | ||
| LOK | |0 004 1727468880 | ||
| LOK | |0 005 20210930153725 | ||
| LOK | |0 008 200819||||||||||||||||ger||||||| | ||
| LOK | |0 040 |a DE-Tue135 |c DE-627 |d DE-Tue135 | ||
| LOK | |0 092 |o n | ||
| LOK | |0 852 |a DE-Tue135 | ||
| LOK | |0 852 1 |9 00 | ||
| LOK | |0 935 |a ixzs |a ixzo | ||
| LOK | |0 936ln |0 1550736558 |a NCH | ||
| LOK | |0 936ln |0 1550736965 |a ZC | ||
| LOK | |0 936ln |0 1442053798 |a XA | ||
| ORI | |a SA-MARC-ixtheoa001.raw | ||
| REL | |a 1 | ||
| STA | 0 | 0 | |a Enhancement,Regulation |
| STB | 0 | 0 | |a Amélioration humaine,Régulation |
| STC | 0 | 0 | |a Mejoramiento humano,Regularización |
| STD | 0 | 0 | |a Enhancement <etica medica>,Potenziamento (etica medica),Potenziamento,Regolazione |
| STF | 0 | 0 | |a 神經增強 |
| STG | 0 | 0 | |a Melhoramento humano,Regularização |
| STH | 0 | 0 | |a Регуляция,Улучшение (медицинская этика) |
| STI | 0 | 0 | |a Ενίσχυση <ιατρική ηθική>,Βελτίωση (ιατρική ηθική),Ενδυνάμωση (ιατρική ηθική),Ρύθμιση |
| SUB | |a REL | ||
| SYE | 0 | 0 | |a Human enhancement |